Clinical Trial Update: Alzheimer's Tau Platform: Regimen A - AADvac1 [Phase 2]

View source ↗

Summary

Phase 2 trial update for AADvac1, an Alzheimer's tau-targeting vaccine, under Regimen A, focusing on preclinical/prodromal Alzheimer's disease; the study is not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• AADvac1

Snippet

Sponsor: Paul S. Aisen | Conditions: Preclinical Alzheimer's Disease, Prodromal Alzheimer's Disease | Phase 2 | Status: NOT_YET_RECRUITING